National Cancer Institute
Found 46 results for your search:
Total relevant funding to Neurofibromatosis for this search:
$8,057,361
Fiscal Year FY 2016
Research Topic [Neurofibromatosis]
Modify this Search New Search
Close

Modify Search Criteria

Some search criteria may be modified to refine your current search.

Select criteria to modify:

Add or remove search options:

Select criteria above to see additional search options

Cancel
Showing 1 - 46 of 46 results
Clipboard
Project Title Sorted ascending Project Number Funded Amount
Relevant Funding
Principal
Investigator
Institution
1
(PQ 6) Exploiting Frequent Alterations in the PRC2 Complex to Distinguish Benign Neurofibromas from Malignant Peripheral Nerve Sheath Tumors 1R21CA208723-01 $212,824 $212,824 BETTEGOWDA, CHETAN JOHNS HOPKINS UNIVERSITY
2
Axl receptor signaling in MPNST; potential node for therapy 4K08CA160443-05 $170,618 $85,309 TORRES, KEILA UNIVERSITY OF TX MD ANDERSON CAN CTR
3
Cancer Center Support Grant 3P30CA082103-18S1 $121,856 $1,219 ASHWORTH, ALAN UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
4
Cancer Center Support Grant 3P30CA082103-18S2 $155,534 $1,555 ASHWORTH, ALAN UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
5
Cancer Center Support Grant 3P30CA082103-18S3 $60,000 $600 ASHWORTH, ALAN UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
6
Cancer Center Support Grant 3P30CA082103-18S4 $80,100 $801 ASHWORTH, ALAN UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
7
Cancer Center Support Grant 3P30CA082103-18S5 $200,000 $2,000 ASHWORTH, ALAN UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
8
Cancer Center Support Grant 3P30CA082103-18S6 $152,100 $1,521 ASHWORTH, ALAN UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
9
Cancer Center Support Grant 3P30CA082103-18S7 $200,000 $2,000 ASHWORTH, ALAN UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
10
Cancer Center Support Grant 3P30CA082103-18S8 $749,207 $7,492 ASHWORTH, ALAN UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
11
Cancer Center Support Grant 4P30CA082103-18 $7,063,742 $70,637 ASHWORTH, ALAN UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
12
Cancer Center Support Grant 3P30CA091842-15S1 $124,686 $2,494 EBERLEIN, TIMOTHY WASHINGTON UNIVERSITY
13
Cancer Center Support Grant 3P30CA091842-15S2 $149,999 $3,000 EBERLEIN, TIMOTHY WASHINGTON UNIVERSITY
14
Cancer Center Support Grant 3P30CA091842-15S3 $497,258 $9,945 EBERLEIN, TIMOTHY WASHINGTON UNIVERSITY
15
Cancer Center Support Grant 5P30CA091842-15 $4,305,712 $86,114 EBERLEIN, TIMOTHY WASHINGTON UNIVERSITY
16
Cancer Center Support Grant - UT Southwestern Medical Center 3P30CA142543-07S1 $200,000 $4,000 COBB, MELANIE UT SOUTHWESTERN MEDICAL CENTER
17
Cancer Center Support Grant - UT Southwestern Medical Center 5P30CA142543-07 $2,479,396 $49,588 COBB, MELANIE UT SOUTHWESTERN MEDICAL CENTER
18
Comprehensive Cancer Center Program at Fox Chase 2P30CA006927-51 $2,675,570 $267,557 FISHER, RICHARD RESEARCH INST OF FOX CHASE CAN CTR
19
Comprehensive Cancer Center Program at Fox Chase 3P30CA006927-51S1 $250,000 $25,000 FISHER, RICHARD RESEARCH INST OF FOX CHASE CAN CTR
20
Comprehensive Cancer Center Program at Fox Chase 3P30CA006927-51S2 $125,000 $12,500 FISHER, RICHARD RESEARCH INST OF FOX CHASE CAN CTR
21
Comprehensive Cancer Center Program at Fox Chase 3P30CA006927-51S3 $133,875 $13,388 FISHER, RICHARD RESEARCH INST OF FOX CHASE CAN CTR
22
Comprehensive Cancer Center Program at Fox Chase 3P30CA006927-51S4 $50,000 $5,000 FISHER, RICHARD RESEARCH INST OF FOX CHASE CAN CTR
23
Comprehensive Cancer Center Program at Fox Chase 3P30CA006927-51S5 $59,999 $6,000 FISHER, RICHARD RESEARCH INST OF FOX CHASE CAN CTR
24
Comprehensive Cancer Center Program at Fox Chase 3P30CA006927-51S6 $200,000 $20,000 FISHER, RICHARD RESEARCH INST OF FOX CHASE CAN CTR
25
DEFINING RISK FACTORS FOR NF1-OPTIC GLIOMA 1R01CA214146-01A1 $348,844 $348,844 GUTMANN, DAVID WASHINGTON UNIVERSITY
26
Developing Endpoints to Facilitate Clinical Trials in Rare Diseases 1R13CA203289-01 $3,993 $3,993 PLOTKIN, SCOTT MASSACHUSETTS GENERAL HOSPITAL
27
Development of Natural Product Leads as Anticancer Therapeutics ZIA BC 011470 $280,052 $56,010 Beutler, John CCR (NCI)
28
Developmental and HyperActive Ras Tumor SPORE 5U54CA196519-02 $2,162,000 $1,816,080 CLAPP, DAVID INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS
29
Elucidating the Regulation and Function of the NF1 tumor suppressor 2R01CA111754-11A1 $316,635 $316,635 CICHOWSKI, KAREN BRIGHAM AND WOMEN'S HOSPITAL
30
Exploration of Activity of RAD001 in vivo in Vestibular Schwannomas and Meningiom 4R01CA164295-05 $1 $1 KARAJANNIS, MATTHIAS NEW YORK UNIVERSITY SCHOOL OF MEDICINE
31
Families at high risk of cancer ZIA CP004410-08285 $198,789 $13,915 Caporaso, Neil DCEG (NCI)
32
Genomic dissection of tumor heterogeneity and progression ZIA BC 011734 $141,223 $141,223 Shern, John CCR (NCI)
33
Hodgkin's families ZIA CP004410-08167 $30,637 $13,787 Goldin, Lynn DCEG (NCI)
34
New Ways of Targeting K-Ras 1R35CA197709-01 $932,874 $466,437 MCCORMICK, FRANK UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
35
Pediatric Oncology Branch Behavioral Science Core ZID BC 011517 $835,175 $417,587 Glod, John CCR (NCI)
36
Pediatric Oncology Branch Clinical Care and Education ZIE BC 011516 $3,340,699 $668,140 Glod, John CCR (NCI)
37
Phase II trial of mTORC1/mTORC2 inhibitor AZD2014 for sporadic meningioma 1R01CA201130-01A1 $400,389 $400,389 RAMESH, VIJAYA MASSACHUSETTS GENERAL HOSPITAL
38
Role of Neurotrophins in the Development of the Mammalian Nervous System ZIA BC 010390 $509,589 $101,918 Tessarollo, Lino CCR (NCI)
39
Role of STE20 protein kinases in malignant mesothelioma 2R01CA148805-06 $423,938 $423,938 CHERNOFF, JONATHAN RESEARCH INST OF FOX CHASE CAN CTR
40
SARC Sarcoma SPORE 3U54CA168512-05S1 $47,692 $4,292 BAKER, LAURENCE SARC
41
SARC Sarcoma SPORE 4U54CA168512-05 $2,161,999 $194,580 BAKER, LAURENCE SARC
42
SEVERABLE FUNDING FOR NCI-FREDERICK 261200800001E $248,730,791 $13,348 UNKNOWN, UNKNOWN LEIDOS BIOMEDICAL RESEARCH, INC.
43
Study of Anti-Survival signals in NF1 4R01CA153354-05 $322,663 $322,663 CHEN, CHANGYAN NORTHEASTERN UNIVERSITY
44
Targeting the Kinome in Neurofibromatosis type 1 5R01CA142928-07 $423,938 $423,938 CHERNOFF, JONATHAN RESEARCH INST OF FOX CHASE CAN CTR
45
The Roles of Tumor Microenvironment in Neurofibroma Development and Therapeutics 4R01CA166593-05 $329,925 $329,925 LE, LU UT SOUTHWESTERN MEDICAL CENTER
46
Therapy for NF1-Related Tumors and other Genetic Tumor Predisposition Syndromes ZIA BC 010801 $689,174 $689,174 Widemann, Brigitte CCR (NCI)
Total relevant funding to Neurofibromatosis for this search: $8,057,361
Showing 1 - 46 of 46 results
Go to top